Large-scale human clinical trials on GHK-Cu remain limited
Adjustments to diabetes medications might be needed to maintain glycemic control
Gpx has been shown to degrade lipid hydroperoxides to their respective alcohols and free hydrogen peroxide to water [82, 83], hence reducing oxidative damage [81]
They are not inevitable or irreversible, but they do warrant attention rather than being treated as an acceptable side effect to push through
(If the patient already has central access, you can give D20W or D50W via central access
A recent pilot study revealed that both PWS and obese patients (n=8 and 11, respectively) who were administered a single 10-g exenatide injection or placebo in a single-blinded, crossover design showed increased satiety, lowered glucose level, and insulinotropic effects [8]